ES2046282T3 - Un procedimiento para preparar un derivado imida de aminoacido n-sustituido. - Google Patents

Un procedimiento para preparar un derivado imida de aminoacido n-sustituido.

Info

Publication number
ES2046282T3
ES2046282T3 ES198888121408T ES88121408T ES2046282T3 ES 2046282 T3 ES2046282 T3 ES 2046282T3 ES 198888121408 T ES198888121408 T ES 198888121408T ES 88121408 T ES88121408 T ES 88121408T ES 2046282 T3 ES2046282 T3 ES 2046282T3
Authority
ES
Spain
Prior art keywords
imida
derivative
preparing
procedure
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES198888121408T
Other languages
English (en)
Inventor
Yoshiaki Cno Zeria Pharmaceutical Co. Ltd Tanaka
Tomoji Cno Zeria Pharmaceutical Co. Ltd Aotsuka
Naomi Cno Zeria Pharmaceutical Co. Ltd Kobayashi
Naoki Cno Zeria Pharmaceutical Co. Ltd Nakata
Kuniyoshi Cno Zeria Pharmaceutical Co. Ltd Ogura
Motoki Cno Zeria Pharmaceutical Co. Ltd Torizuka
Naoyoshi Cno Zeria Pharmaceutical Co. Ltd Miura
Heihachiro Cno Zeria Pharmaceutical Co. Ltd Arai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zeria Pharmaceutical Co Ltd
Original Assignee
Zeria Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zeria Pharmaceutical Co Ltd filed Critical Zeria Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ES2046282T3 publication Critical patent/ES2046282T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/04—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D277/06—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

SE DESCUBRE NUEVO AMINO ACIDO DERIVADO DE AMINA, N SUSTITUIDO. LOS COMPUESTOS SON REPRESENTADOS POR FORMULA COMPLEJA CON N REPRESENTANDO UN ENTERO DE 0 A 5, Y X E Y, LAS CUALES PUEDEN SER LO MISMO O DIFERENTES, REPRESENTAN UN GRUPO METILENO O UN ATOMO DE AZUFRE, SIN QUE AMBOS X E Y SEAN GRUPOS METILENO A LA VEZ. LOS COMPUESTOS SE USAN COMO MEDICINA PARA TRATAR O PREVENIR DESORDENES DE CIRCULACION CEREBRAL, DESORDENES DE METABOLISMO CEREBRAL O DISTURBIOS DE MEMORIA.
ES198888121408T 1987-12-23 1988-12-21 Un procedimiento para preparar un derivado imida de aminoacido n-sustituido. Expired - Lifetime ES2046282T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP32654987 1987-12-23
JP63256940A JPH01250370A (ja) 1987-12-23 1988-10-14 新規アミノ酸イミド誘導体、製法ならびに用途

Publications (1)

Publication Number Publication Date
ES2046282T3 true ES2046282T3 (es) 1994-02-01

Family

ID=26542971

Family Applications (1)

Application Number Title Priority Date Filing Date
ES198888121408T Expired - Lifetime ES2046282T3 (es) 1987-12-23 1988-12-21 Un procedimiento para preparar un derivado imida de aminoacido n-sustituido.

Country Status (5)

Country Link
US (1) US4916146A (es)
EP (1) EP0321956B1 (es)
JP (1) JPH01250370A (es)
DE (1) DE3876400T2 (es)
ES (1) ES2046282T3 (es)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2649237B2 (ja) * 1988-03-07 1997-09-03 キッセイ薬品工業 株式会社 チアゾリジン誘導体
JPH0832704B2 (ja) * 1987-11-30 1996-03-29 キッセイ薬品工業株式会社 プロリルエンドペプチダーゼ阻害剤
JP2515568B2 (ja) * 1987-12-25 1996-07-10 株式会社ヤクルト本社 新規なチアゾリジン誘導体
JP2674703B2 (ja) * 1988-05-30 1997-11-12 サントリー株式会社 新規チアゾリジン誘導体及びその用途
CA2004028C (en) * 1988-12-08 1998-09-22 Motoki Torizuka Condensed benzene derivative
JPH0662591B2 (ja) * 1988-12-14 1994-08-17 株式会社ヤクルト本社 新規なチオプロリン誘導体
US5118811A (en) * 1989-04-13 1992-06-02 Japan Tobacco Inc. Amino acid derivatives possessing prolyl endopeptidase-inhibitory activities
ATE133407T1 (de) * 1990-06-07 1996-02-15 Zeria Pharm Co Ltd Neue arylalkanoylaminderivate und diese enthaltendes arzneimittel
FR2681864B1 (fr) * 1991-09-27 1995-03-31 Adir Nouveaux derives bicycliques azotes, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
JP3810097B2 (ja) * 1993-01-15 2006-08-16 明治製菓株式会社 ピロリジン−２−イルカルボニル複素環式化合物誘導体
FR2703050B1 (fr) * 1993-03-24 1995-04-28 Adir Nouveaux dérivés bicycliques azotés, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
JP2973271B2 (ja) * 1994-01-18 1999-11-08 参天製薬株式会社 エンドペプチダーゼ２４．１５阻害剤
US6218424B1 (en) * 1996-09-25 2001-04-17 Gpi Nil Holdings, Inc. Heterocyclic ketone and thioester compounds and uses
SI0915088T1 (en) * 1997-10-31 2002-12-31 F. Hoffmann-La Roche Ag D-proline derivatives
EP1620091B1 (en) 2003-05-05 2010-03-31 Probiodrug AG Inhibitors of glutaminyl cyclase
FI20031018A0 (fi) * 2003-07-04 2003-07-04 Orion Corp Parannus aivovammasta toipumiseen
NZ546887A (en) 2003-11-03 2009-04-30 Probiodrug Ag Combinations useful for the treatment of neuronal disorders
KR101099206B1 (ko) 2004-02-05 2011-12-27 프로비오드룩 아게 신규한 글루타미닐 시클라제 저해제
WO2008055945A1 (en) 2006-11-09 2008-05-15 Probiodrug Ag 3-hydr0xy-1,5-dihydr0-pyrr0l-2-one derivatives as inhibitors of glutaminyl cyclase for the treatment of ulcer, cancer and other diseases
WO2008065141A1 (en) 2006-11-30 2008-06-05 Probiodrug Ag Novel inhibitors of glutaminyl cyclase
EP2481408A3 (en) 2007-03-01 2013-01-09 Probiodrug AG New use of glutaminyl cyclase inhibitors
EP2865670B1 (en) 2007-04-18 2017-01-11 Probiodrug AG Thiourea derivatives as glutaminyl cyclase inhibitors
US8486940B2 (en) 2009-09-11 2013-07-16 Probiodrug Ag Inhibitors
JP6026284B2 (ja) 2010-03-03 2016-11-16 プロビオドルグ エージー グルタミニルシクラーゼの阻害剤
EP2545047B9 (en) 2010-03-10 2015-06-10 Probiodrug AG Heterocyclic inhibitors of glutaminyl cyclase (qc, ec 2.3.2.5)
EP2560953B1 (en) 2010-04-21 2016-01-06 Probiodrug AG Inhibitors of glutaminyl cyclase
JP6050264B2 (ja) 2011-03-16 2016-12-21 プロビオドルグ エージー グルタミニルシクラーゼの阻害剤としてのベンゾイミダゾール誘導体
PL3461819T3 (pl) 2017-09-29 2020-11-30 Probiodrug Ag Inhibitory cyklazy glutaminylowej

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0036713B1 (en) * 1980-03-05 1984-01-18 University Of Miami Angiotensin converting enzyme inhibitors
JPH0662529B2 (ja) * 1984-07-13 1994-08-17 三共株式会社 アミノ酸誘導体
CA1320734C (en) * 1986-02-04 1993-07-27 Suntory Limited Pyrrolidineamide derivative of acylamino acid and pharmaceutical composition containing the same
EP0280956B1 (en) * 1987-02-23 1992-10-21 Ono Pharmaceutical Co., Ltd. Thiazolidine derivatives
US4857524A (en) * 1987-08-08 1989-08-15 Kissei Pharmaceutical Co., Ltd. Thiazolidine compounds and therapeutic method

Also Published As

Publication number Publication date
EP0321956B1 (en) 1992-12-02
JPH01250370A (ja) 1989-10-05
EP0321956A1 (en) 1989-06-28
US4916146A (en) 1990-04-10
DE3876400D1 (de) 1993-01-14
DE3876400T2 (de) 1993-05-13

Similar Documents

Publication Publication Date Title
ES2046282T3 (es) Un procedimiento para preparar un derivado imida de aminoacido n-sustituido.
ES2059383T3 (es) Compuestos de diamina.
RO84704A (ro) Procedeu pentru prepararea unor derivati de n-piperidinil-benzamide
PT93947A (pt) Processo para a preparacao de novos derivados de maleinimidas e de composicoes farmaceuticas que os contem
PA8539801A1 (es) Derivados del ácido isoftálico como inhibidores de metaloproteinasas de la matriz
ES2043617T3 (es) Un procedimiento para preparar derviados de benzamida.
DK239581A (da) Fremgangsmaade til fremstilling af p-substituerede 3-fenoxy-1-alkylaminopropanoler
ES2072263T3 (es) Derivados de 4-aminopiridina.
ES464145A1 (es) Procedimiento de preparacion de compuestos derivados de la piperidina.
ES8200094A1 (es) Procedimiento para la obtencion de alquilureas
HK12284A (en) New substituted heterocyclic benzamides,methods of preparing them,compositions containing them,and their use as behaviour modifiers
DK165919C (da) N-substituerede 3-piperidin- eller 3-pyridincarboxylsyrederivater, fremgangsmaade til fremstilling heraf og farmaceutiske praeparater indeholdende forbindelserne
ES2068742B1 (es) Nuevos derivados de piridinio.
ES2029879T3 (es) Procedimiento para producir derivados de aminas sustituidas.
ES532322A0 (es) Procedimiento para preparar derivados de 4-oxo-tiazolidin-2-iliden-acetamida.
HU9401968D0 (en) Pharmaceutical compositions and process for producing them
DE3164667D1 (en) Amino-alcoxy pyrazoles, process for their preparation and medicaments containing them
BR7605977A (pt) Processo para a preparacao de derivados de n-(1,2,4-triazin-5-on-4-il)glicina,bem como composicoes herbecidas a base destes
PT632028E (pt) Derivado opticamente activo do 2-nitroimidazole processo para a producao do mesmo e intermediario para a producao do mesmo
PT94103A (pt) Processo para a preparacao de agentes anticonvulsivos a base de derivados amino-acidos
ES8203843A1 (es) Procedimiento para la obtencion de amidas de acido 1,4-dihi-dropiridin-4-carboxilico
ES2055440T3 (es) Derivados del acido quinurenico, su preparacion y composiciones farmaceuticas que los contienen.
PT82634B (pt) Processo para a preparacao de novos compostos alcaloides contendo um nucleo berbano uteis como medicamentos
ES2031921T3 (es) Derivados 5-aminoetilados de la oxazolidinona-2, su procedimiento de fabricacion y su aplicacion terapeutica.
ES2042755T3 (es) Procedimiento de preparacion de esteres alquilo ramificados del acido 4-bis(cloroetil)aminofenil-alquil carboxilico.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 321956

Country of ref document: ES